1-3 of 3
Lea Burke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

INCB057643, a bromodomain and extra-terminal protein inhibitor, in combination with ruxolitinib in patients with myelofibrosis: A phase 1 study of safety and efficacy

Free
Justin Watts, Anthony Hunter, Junichiro Yuda, Ahmed Abdulgawad, Anna Halpern, María Teresa Gómez Casares, Ellen Ritchie, Rosa Ayala Diaz, Francesca Palandri, Alessandra Iurlo, Jesus Maria Hernandez Rivas, Vikas Gupta, Keita Kirito, Brandi Reeves, Pankit Vachhani, Prithviraj Bose, Massimiliano Bonifacio, Brandon McMahon, Srinivas Tantravahi, Jun Choi, Alessandro Lucchesi, Kittika Poonsombudlert, Lea Burke, Feng Zhou, Fred Zheng, Alessandro Maria Vannucchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 5574.
https://doi.org/10.1182/blood-2025-5574
Published: 2025
Journal Articles

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Available to Purchase
Clinical Trials & Observations
Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael Pratta, Rodica Morariu-Zamfir, John F. DiPersio
Journal: Blood
Blood (2025) 146 (4): 422–436.
https://doi.org/10.1182/blood.2024026586
Published: 2025
Includes: Supplemental data
Journal Articles

JAK1 Inhibition during CAR T-Cell Treatment Does Not Affect CAR T-Cell Proliferation, Persistence, or Function

Free
Michael Pratta, Lea Burke, John F. DiPersio, Richard T. Maziarz, Patricia Feldman, Teresa Brodeur, Cynthia Timmers, Olga Ivanova, April Barbour, Rodica Morariu-Zamfir, Matthew Frigault
Journal: Blood
Blood (2022) 140 (Supplement 1): 10350–10351.
https://doi.org/10.1182/blood-2022-169382
Published: 2022